Lewinsohn, Deborah A.
Swarbrick, Gwendolyn M.
Park, Byung
Cansler, Meghan E.
Null, Megan D.
Toren, Katelynne G.
Baseke, Joy
Zalwango, Sarah
Mayanja-Kizza, Harriet
Malone, LaShaunda L.
Nyendak, Melissa
Wu, Guanming
Guinn, Kristi
McWeeney, Shannon http://orcid.org/0000-0001-8333-6607
Mori, Tomi
Chervenak, Keith A.
Sherman, David R.
Boom, W. Henry
Lewinsohn, David M.
Article History
Received: 11 August 2016
Revised: 18 January 2017
Accepted: 31 January 2017
First Online: 3 April 2017
Competing interests
: Aeras TB Vaccine Foundation, a non-profit organization, has licensed technology from OHSU of which Drs. David and Deborah Lewinsohn are inventors and which is used in this research. In addition, OHSU and Drs. David Lewinsohn, Deborah Lewinsohn, and Melissa Nyendak have a financial interest in, and Ms. Cansler, Ms. Null, and Ms. Swarbrick are employees of, ViTi, a company that may have a commercial interest in the results of this research and technology. These potential individual and institutional conflicts of interest have been reviewed and managed by OHSU.